673 related articles for article (PubMed ID: 27068454)
61. Development and Evaluation of a Cryopreserved Whole-Parasite Vaccine in a Rodent Model of Blood-Stage Malaria.
Stanisic DI; Ho MF; Nevagi R; Cooper E; Walton M; Islam MT; Hussein WM; Skwarczynski M; Toth I; Good MF
mBio; 2021 Oct; 12(5):e0265721. PubMed ID: 34663097
[TBL] [Abstract][Full Text] [Related]
62. DAF-shielded baculovirus-vectored vaccine enhances protection against malaria sporozoite challenge in mice.
Iyori M; Yamamoto DS; Sakaguchi M; Mizutani M; Ogata S; Nishiura H; Tamura T; Matsuoka H; Yoshida S
Malar J; 2017 Sep; 16(1):390. PubMed ID: 28962615
[TBL] [Abstract][Full Text] [Related]
63. Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii.
Grillot D; Michel M; Müller I; Tougne C; Rènia L; Mazier D; Corradin G; Lambert PH; Louis JA; Del Guidice G
Eur J Immunol; 1990 Jun; 20(6):1215-22. PubMed ID: 1695152
[TBL] [Abstract][Full Text] [Related]
64. A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of Plasmodium falciparum.
Radin K; Clement F; Jongert E; Sterckx YG; Ockenhouse C; Regules J; Lemiale F; Leroux-Roels G
Malar J; 2016 Nov; 15(1):543. PubMed ID: 27825382
[TBL] [Abstract][Full Text] [Related]
65. Effects of transmission-blocking vaccines simultaneously targeting pre- and post-fertilization antigens in the rodent malaria parasite Plasmodium yoelii.
Zheng L; Pang W; Qi Z; Luo E; Cui L; Cao Y
Parasit Vectors; 2016 Aug; 9(1):433. PubMed ID: 27502144
[TBL] [Abstract][Full Text] [Related]
66. Serum antibody immunoglobulin G of mice convalescent from Plasmodium yoelii infection inhibits growth of Plasmodium falciparum in vitro: blood stage antigens of P. falciparum involved in interspecies cross-reactive inhibition of parasite growth.
Ray P; Sahoo N; Singh B; Kironde FA
Infect Immun; 1994 Jun; 62(6):2354-61. PubMed ID: 8188358
[TBL] [Abstract][Full Text] [Related]
67. Recombinant pseudorabies virus carrying a plasmodium gene: herpesvirus as a new live viral vector for inducing T- and B-cell immunity.
Sedegah M; Chiang CH; Weiss WR; Mellouk S; Cochran MD; Houghten RA; Beaudoin RL; Smith D; Hoffman SL
Vaccine; 1992; 10(9):578-84. PubMed ID: 1323900
[TBL] [Abstract][Full Text] [Related]
68.
Kusi KA; Amoah LE; Acquah FK; Ennuson NA; Frempong AF; Ofori EA; Akyea-Mensah K; Kyei-Baafour E; Osei F; Frimpong A; Singh SK; Theisen M; Remarque EJ; Faber BW; Belmonte M; Ganeshan H; Huang J; Villasante E; Sedegah M
Front Cell Infect Microbiol; 2024; 14():1375249. PubMed ID: 38808064
[TBL] [Abstract][Full Text] [Related]
69. Co-expression of Interleukin-15 Enhances the Protective Immune Responses Induced by Immunization with a Murine Malaria MVA-Based Vaccine Encoding the Circumsporozoite Protein.
Parra M; Liu X; Derrick SC; Yang A; Molina-Cruz A; Barillas-Mury C; Zheng H; Thao Pham P; Sedegah M; Belmonte A; Litilit DD; Waldmann TA; Kumar S; Morris SL; Perera LP
PLoS One; 2015; 10(10):e0141141. PubMed ID: 26505634
[TBL] [Abstract][Full Text] [Related]
70. Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses.
Janitzek CM; Matondo S; Thrane S; Nielsen MA; Kavishe R; Mwakalinga SB; Theander TG; Salanti A; Sander AF
Malar J; 2016 Nov; 15(1):545. PubMed ID: 27825348
[TBL] [Abstract][Full Text] [Related]
71. A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii.
Burns JM; Majarian WR; Young JF; Daly TM; Long CA
J Immunol; 1989 Oct; 143(8):2670-6. PubMed ID: 2477452
[TBL] [Abstract][Full Text] [Related]
72. Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii.
Tian JH; Kumar S; Kaslow DC; Miller LH
Infect Immun; 1997 Aug; 65(8):3032-6. PubMed ID: 9234750
[TBL] [Abstract][Full Text] [Related]
73. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.
Bergmann ES; Ballou RW; Krzych U
Cell Immunol; 1997 Sep; 180(2):143-52. PubMed ID: 9341744
[TBL] [Abstract][Full Text] [Related]
74. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum.
Xu L; Pei X; Berzins K; Chaudhuri A
Exp Parasitol; 2007 Jul; 116(3):214-24. PubMed ID: 17336297
[TBL] [Abstract][Full Text] [Related]
75. Transgenic Plasmodium that expresses HIV-1 Gag elicits immunity and protects mice against vaccinia virus-gag and malarial parasites.
Jiang B; Qin L; Du Y; Peng N; Chen L; Chen Z; Chen X
Vaccine; 2010 Nov; 28(50):7915-22. PubMed ID: 20933565
[TBL] [Abstract][Full Text] [Related]
76. Adeno-Associated Virus as an Effective Malaria Booster Vaccine Following Adenovirus Priming.
Yusuf Y; Yoshii T; Iyori M; Yoshida K; Mizukami H; Fukumoto S; Yamamoto DS; Alam A; Emran TB; Amelia F; Islam A; Otsuka H; Takashima E; Tsuboi T; Yoshida S
Front Immunol; 2019; 10():730. PubMed ID: 31024558
[TBL] [Abstract][Full Text] [Related]
77. Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii.
Kawabata Y; Udono H; Honma K; Ueda M; Mukae H; Kadota J; Kohno S; Yui K
Infect Immun; 2002 Nov; 70(11):6075-82. PubMed ID: 12379684
[TBL] [Abstract][Full Text] [Related]
78. Effect of ingested human antibodies induced by RTS, S/AS01 malaria vaccination in children on Plasmodium falciparum oocyst formation and sporogony in mosquitoes.
Miura K; Jongert E; Deng B; Zhou L; Lusingu JP; Drakeley CJ; Fay MP; Long CA; Vekemans J
Malar J; 2014 Jul; 13():263. PubMed ID: 25007730
[TBL] [Abstract][Full Text] [Related]
79. Vaxfectin enhances both antibody and in vitro T cell responses to each component of a 5-gene Plasmodium falciparum plasmid DNA vaccine mixture administered at low doses.
Sedegah M; Rogers WO; Belmonte M; Belmonte A; Banania G; Patterson NB; Rusalov D; Ferrari M; Richie TL; Doolan DL
Vaccine; 2010 Apr; 28(17):3055-65. PubMed ID: 19879998
[TBL] [Abstract][Full Text] [Related]
80. Novel antigen identification method for discovery of protective malaria antigens by rapid testing of DNA vaccines encoding exons from the parasite genome.
Haddad D; Bilcikova E; Witney AA; Carlton JM; White CE; Blair PL; Chattopadhyay R; Russell J; Abot E; Charoenvit Y; Aguiar JC; Carucci DJ; Weiss WR
Infect Immun; 2004 Mar; 72(3):1594-602. PubMed ID: 14977966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
